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ABSTRACT
Introduction Prevalence of overweight, obesity and 
diabetes are high and rising across the Gulf Cooperation 
Council (GCC) countries (Oman, Bahrain, Kuwait, Qatar, 
Saudi Arabia and the United Arab Emirates). In parallel, 
physical activity (PA) levels are low relative to international 
standards. PA aids weight control and reduces risk of 
non- communicable diseases including diabetes and 
cardiovascular disease. It is likely interventions developed 
elsewhere will not translate to GCC countries due to 
unique environmental, social and cultural factors. This 
protocol is for a systematic review assessing the efficacy 
of interventions promoting PA within GCC countries 
among generally healthy adults and children. The primary 
outcome of interest is change in objectively measured 
or self- reported PA levels, the secondary outcomes of 
interest are changes in anthropometry or chronic disease 
risk factors (eg, blood pressure). Interventions will be 
compared with no intervention or those of differing PA 
intensity or duration. The relationships between PA change 
and the following will be assessed: intervention intensity 
or duration, season in which intervention occurs, sex, age, 
nationality and sustainability over time.
Methods and analysis A systematic search strategy 
will identify indexed publications on the efficacy of 
interventions promoting PA. Randomised controlled trials 
and quasi- experimental studies recruiting predominantly 
healthy children and adults will be included. Studies of 
exercise rehabilitation will be excluded. Medline, Embase, 
Cinahl, Cochrane Library, SportDiscus, Web of Science, 
Index Medicus for the Eastern Mediterranean Region 
and Qscience will be searched. Clinical trial registries 
including the International Clinical Trials Registry Platform, 
the Iranian Registry of Clinical Trials and  ClinicalTrials. 
gov will be searched for ongoing and unpublished studies. 
Searches will be ran from database inception until 1 May 
2020 and be supplemented by checking references of key 
articles. Two reviewers will independently screen identified 
citations then full texts using prespecified inclusion and 
exclusion criteria. Piloted data extraction forms will be 
used in duplicate. Inconsistencies in screening or data 
extraction will be resolved by a third investigator or study 
author contact. Risk of bias will be independently assessed 
by two reviewers using validated tools. A narrative 
summary of findings will be produced supplemented 
with meta- analyses and exploration of heterogeneity as 
appropriate.
Ethics and Dissemination The review aims to strengthen 
the findings of the primary studies it incorporates and 
explore the impact of setting. It will synthesise existing 
published aggregate patient data. If publications or data 
with ethical concerns are identified, they will be excluded 
from the review. Results of the systematic review will 
be published in full and authors will engage directly 
with research audiences and key stakeholders to share 
findings.
PROSPERO registration number 131817.
Strengths and limitations of this study
 ► The methodology of this systematic review follows 
a standard approach and is being made transparent 
apriori with registration on PROSPERO and publica-
tion within BMJ Open.
 ► Risk of bias is being assessed for each study using 
a validated tool appropriate for each study’s design. 
As well as this, the Grading of Recommendations, 
Assessment, Development and Evaluations ap-
proach is being used to assess the certainty of 
the evidence contributing to each outcome being 
reported.
 ► Appropriate analysis plans have been specified 
based on the evidence identified. For example, meta- 
analysis will only be completed contingent on the 
level of clinical diversity and risk of bias identified.
 ► The search strategy for grey literature in this review 
is limited; however, regional databases and relevant 
clinical trial registries have been included.
 ► Given the aim of the review, geographical setting 
has been made an inclusion and exclusion crite-
ria. Although this decision was made to align with 
the review’s primary aim, it means there will be no 
ability to compare intervention efficacy across more 
heterogeneous geographical settings.
 o
n
 Septem
ber 1, 2020 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2020-037122 on 20 August 2020. Downloaded from 
2 Pearson F, et al. BMJ Open 2020;10:e037122. doi:10.1136/bmjopen-2020-037122
Open access 
BACKGROUND
The prevalence of overweight and obesity among adults 
residing in the six Gulf Cooperation Council (GCC) 
countries (Oman, Bahrain, Kuwait, Qatar, Saudi Arabia 
and the United Arab Emirates) is very high ranging 
from 69% to 86%.1–3 In addition, obesity and alarm-
ingly type 2 diabetes mellitus (T2DM) are becoming 
increasingly common in the child and adolescent popu-
lation (<18 years old).4 5 Overweight and obesity are 
chronic health statuses associated with high morbidity 
and mortality rates. In particular, increased body mass 
index (BMI) is a major risk factor for cardiovascular 
disease, diabetes mellitus, musculoskeletal disorders 
and cancer.6 7 BMI is largely influenced by energy intake 
and calorie control, but increasing physical activity can 
contribute to increased weight loss and weight mainte-
nance.8 Evidence indicates that physical activity (PA) 
can improve cardiovascular fitness and insulin sensi-
tivity, reduce incidence of T2DM, improve glycaemic 
control for people living with T2DM, lower blood pres-
sure, lower risk of depression and anxiety,9 and reduce 
risks of certain cancers.10 PA can also improve cognitive 
function and reduce risks of dementia.10
PA is defined as any bodily movement produced by 
skeletal muscles that requires energy expenditure.10 11 
PA includes different forms of exercise (activities that 
are planned and deliberately performed to improve 
physical fitness)12 as well as many activities that are 
completed as part of routine daily life such as active 
transportation, household chores and other recre-
ational activities. PA is often described using ‘FITT’ 
principles (Frequency, Intensity, Time and Type) with 
most intervention studies aiming to increase at least 
moderate or vigorous activities (activities expending at 
least three times more energy than at rest).10 Current 
WHO recommendations for PA levels among adults are 
to reach a target level of 150 min or more of moderate 
PA per week, or 75 min or more of vigorous activities 
(or a combination of the two)13 and 1 hour a day for 
children (aged 5–17).12 However, there is evidence that 
any increase in PA, even below these levels, improves 
cardiovascular health and reduces diabetes risk.12 14
There appears to be a lack of objectively measured data 
on PA in the GCC countries15 and only limited data on 
self- reported PA levels.1 2 However, data from the WHO 
Global Observatory suggest that the Eastern Mediterra-
nean region has the highest regional prevalence of phys-
ical inactivity among both adults (31%) and adolescents 
(87%).10 PA levels are thought to be even lower across 
the GCC due to a range of interrelated region specific 
factors including: climate, lack of facilities and infrastruc-
ture to promote PA (eg, pavements and walking routes), 
high levels of traffic, lack of parental support for children 
to be physically active and, for women, cultural expecta-
tions surrounding PA behaviour.16 17 A recent review from 
the Arab region (which includes the GCC countries) 
found that over 40% of adults were physically inactive in 
most countries, and activity levels among women were 
generally lower than men.17 Activity levels in children were 
also lower than the global average.17 Given both the low 
current levels and regional specific factors, it is thought 
that interventions promoting PA developed and evaluated 
for populations elsewhere (most often Northern Europe 
or North America but even in neighbouring countries) 
may not be appropriate to implement in the Gulf region 
without adjusting for contextual factors and examining 
regional evidence in practice.
A previous narrative review published in 2016 iden-
tified six studies describing PA interventions targeted 
at adults; however, it did not use a very comprehensive 
systematic search strategy, or state clear inclusion and 
exclusion criteria.15 Most of the six studies identified 
were not randomised controlled trials (RCTs) and had 
substantial limitations including small sample sizes and a 
lack of long- term follow- up.15 The review identified that 
greater priority should be given to increasing interven-
tion research to guide national policy and programmes 
on chronic disease prevention including through use of 
PA. At the time of the 2016 review, no studies of phys-
ical activity promotion were identified among children, 
but some school- based studies are now available.18 19 We 
will stratify results by age group (adults or children<16) 
to reflect this important updated information. This 
planned systematic review will include a more compre-
hensive search likely to identify studies previously 
uncaptured within the narrative review, as well as more 
recently published studies18 19 leading to further insights 
being gained from appraising the expanding evidence 
base.
This protocol is for a systematic review of the efficacy 
of interventions that aim to promote any form of phys-
ical activity undertaken within the six GCC countries 
among healthy free- living adults and children. Both post- 
intervention and pre- intervention control groups will be 
included. The review will assess the efficacy of any inter-
vention compared with minimal (eg, brief one- off advice) 
or no intervention at: increasing PA levels from baseline, 
improving cardiovascular and/or metabolic fitness or 
improving anthropometric markers (such as BMI). If 
sufficient numbers of studies are identified, secondary 
aims will be to assess whether longer or more intensive 
interventions (more contacts or sessions per week) result 
in further increases in PA. If later follow- up data are 
available, we will assess whether intervention benefits are 
maintained beyond the end of the intervention period. If 
feasible, we will also perform subgroup analyses to assess 
differences in PA outcomes between men and women. We 
will perform sensitivity analyses to explore which types of 
intervention appear to be most effective among children 
(<16 years) and adults separately, and also among Gulf 
state nationals as well as migrant populations separately. 
If sufficient studies are identified, we will also explore the 
effect of seasonality (spring, autumn, summer or winter) 
on intervention efficacy.
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METHODS AND ANALYSIS
Inclusion criteria
We will include RCTs and any observational studies that 
are quasi- experimental in design. This will include any 
observational studies with a comparator group and also 
difference- in- difference (pre–post- intervention) studies, 
interrupted time series studies and propensity score 
matching studies. We will include studies published in 
English and in Arabic, and do not anticipate identifying 
studies published in any other language.
Participants
Children and adults irrespective of nationality or 
non- communicable diseases (NCD) risk factor status, 
including migrant populations living in the six GCC 
countries. Any trials specifically targeted at patients 
requiring physical exercise for rehabilitation (eg, after a 
stroke, myocardial infarction, joint replacement surgery) 
or pulmonary rehabilitation (eg, patients with Chronic 
Obstructive Pulmonary Disease) will not be included as 
exercise capacity would likely be substantially different 
in these groups and distinct supervised approaches may 
therefore be required.
Intervention
Any form of PA intervention, whether supervised or unsu-
pervised, offered on a repetitive basis over any predefined 
period of time, either in isolation or in combination with 
other intervention components as part of broader life-
style interventions. Types of physical activity programme 
will not be prespecified but might include: web- based 
or mobile phone- based prompts and reminders, group- 
based exercise sessions, walking programmes taking place 
in the community or in workplaces and schools, motiva-
tional messaging and counselling. Studies evaluating only 
brief advice (ie, one- off advice from healthcare practi-
tioners or others) to increase PA will be excluded, except 
when this forms part of the ‘comparator’ group.
Comparison group
The PA intervention will be compared with no interven-
tion, to a control offering brief one- off advice to increase 
PA, to a control containing no PA components, or to a 
control offering PA at different levels of exertion, inten-
sity or duration. Pretest and post- test groups will also be 
included.
Outcome
The primary outcome of interest is a change in level of 
PA, measured by self- reporting (through validated ques-
tionnaires such as the International Physical Activity Ques-
tionnaire)20 21 or through more objective methods such 
as accelerometers, heart rate monitors or step counters. 
Objective methods of measurement are preferred as 
there is some evidence that self- reported measurements 
can significantly overestimate PA levels compared with 
more objective assessments such as by accelerometers,22 
though this has not been a consistent finding.23 24 Quan-
titative data are likely to be available as mean changes in 
PA levels (self- reported or objective) or potentially the 
proportion of the intervention and control arms meeting 
a fixed level of PA (such as 150 min of moderate activity or 
more per week), or participating in group- based sessions 
or specific activities.
Secondary outcomes of interest are weight change 
at any time point, other indicators of body mass and 
anthropometry (eg, BMI, waist circumference, waist‐to‐
hip ratio), and assessment of other cardiovascular and 
metabolic risk markers (eg, blood pressure, blood lipids). 
Other process outcomes such as dropping out from the 
programme, and adherence to group exercise sessions 
will be reported where available.
Setting
‘Healthy’ non- institutionalised adults and children living 
in the community in the six GCC countries. Interventions 
can take place in any setting whether it is home based, 
centre based, community based, worksite or school based.
Search methods
A systematic search strategy will be used to identify a 
broad range of published PA intervention studies among 
adults and children. Searches will be conducted from 
database inception to May 2020 in Medline, Embase, 
Cinahl, Cochrane Library, SportDiscus and Web of 
Science using the proposed search terms set out in online 
supplementary appendix 1 translated for each database. 
We will also search key regional databases and journals 
including Index Medicus for the Eastern Mediterranean 
Region (IMEMR), Qscience (a database in Qatar) and 
Saudi Medical Journal. We will search trial registries for 
information on any unpublished but potentially relevant 
trials including the International Clinical Trials Registry 
Platform, the Iranian Registry of Clinical Trials and  Clin-
icalTrials. gov. Database searches will be supplemented 
by reference and citation checking of key articles, and 
contact with experts.
Data management
All data will be stored centrally and securely using insti-
tutional servers. The review process will be documented 
and an annotated Preferred Reporting Items for System-
atic Reviews and Meta- Analyses flow diagram will be 
produced depicting the number of records initially iden-
tified through the different database searches and other 
forms of searching, the number of records included and 
excluded at each stage of the process and the reasons for 
any exclusions.
Initial citation sifting will be completed independently 
by two investigators in EndNote V.X7 using outlined 
inclusion and exclusion criteria. A 10% pilot of sifting 
will be carried out to assess whether any amendments are 
required to inclusion/exclusion criteria.
As needed, publications will be retrieved in full and 
a prespecified, tested Excel form will be used to assess 
inclusion or exclusion of full text publications. Where 
reviewers disagree on inclusion or exclusion, a third 
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independent reviewer will be consulted or disagreement 
will be resolved by discussion.
Data extraction
A prespecified, tested Excel form will be used for data 
extraction including data on quality and risk of bias. 
Piloting of this data extraction tool will occur in a subsa-
mple of included studies before the full extraction is 
carried out. Data on the following will be extracted inde-
pendently by two investigators: publication characteris-
tics, trial characteristics (design, duration, randomisation, 
allocation concealment, blinding), intervention (exercise 
type/frequency/duration/intensity, comparison, method 
of delivery, season of delivery), participants (gender, age, 
nationality, definition of overweight or obesity, baseline 
characteristics, assessment of compliance or relapse, with-
drawals or losses to follow‐up), subgroups, outcome/
results (activity level, marker of weight loss), other events 
captured (eg, injuries) and length of follow‐up.
Data extraction will be completed independently by 
two investigators and any discrepancies in extraction will 
be resolved through consultation of a third independent 
reviewer. If at any point in the review process, data are 
missing from a primary publication or are unclear, study 
authors will be contacted for clarification.
Assessment of methodological quality
To give a study- centric risk of bias summary, the following 
validated tools will be used: for observational studies, the 
Newcastle Ottawa Score25 or ROBINS- I26; and for RCTs, 
Cochrane Risk of Bias 2.27 To highlight the certainty 
of evidence contributing to each outcome Grading of 
Recommendations, Assessment, Development and Eval-
uations (GRADE), a validated approach, will be used.13 28 
GRADE incorporates its own outcome- centric risk of bias 
assessment. Risk of bias assessment and GRADE will also 
be conducted by two independent reviewers, with any 
disagreements resolved through a third party.
Strategy for data synthesis
The characteristics of each study and intervention will be 
collated in a ‘characteristics of included studies’ table. If 
statistical synthesis of results is not appropriate, a struc-
tured report of the effects will be given. The difference 
in self- reported physical activity, or objectively measured 
physical activity (eg, step counts), or uptake of group- 
based sessions, or participation in specific activities will be 
compared between intervention or comparator groups. 
If statistical pooling is feasible, fixed or random effects 
Mantel- Haenszel models will be produced dependent on 
the heterogeneity present between studies. Heterogeneity 
will be assessed using the χ2 test, the I2 statistic and the 
prediction interval. Given the broad clinical and method-
ological inclusion criteria, it is likely that a random effects 
model will be used. Meta- analyses will be completed using 
STATA V.15 with log files of all sessions stored. If plau-
sible (ie, if there are sufficient studies overall in each 
subcategory) meta- analyses and subgroup analyses will be 
completed by intervention type, age (adults or children), 
sex, nationality, initial weight, comorbidities and levels of 
adherence.
Using subgroup analysis or meta- regression as appro-
priate, potential causes of heterogeneity will be explored 
including: the site of intervention (eg, schools, work-
places, clinic or population based), multicomponent 
interventions (eg, dietary advice, smoking cessation, 
or focussing exclusively on physical activity), mode of 
delivery (eg, online, face to face), intensity and duration 
of the intervention (such as number of contacts with advi-
sors or number of exercise sessions offered) and attrition 
bias (losses to follow- up in each intervention arm <20%, 
intention- to- treat analyses performed).
If sufficient numbers of studies are identified, sensi-
tivity analyses will be completed to explore whether study 
design, study size, study quality, study duration, study 
setting, intervention type, or duration and intensity of 
exercise impact pooled intervention effect estimates. 
Participant characteristics (eg, presence of comorbidities, 
average baseline weight, age group (children or adults), 
biological sex) intervention features, season of interven-
tion and different modes of delivery of the intervention 
will also be noted and considered in sensitivity analyses.
Publication bias will be assessed using funnel plots if 
more than 10 studies are being included within a meta- 
analysis; Egger’s test for bias will also be performed.
Patient and public involvement statement
This protocol was designed without patient involve-
ment. Patients were not invited to comment on the study 
design and were not consulted to develop patient rele-
vant outcomes or interpret the results. Patients were not 
invited to contribute to the writing or editing of this docu-
ment for readability or accuracy.
ETHICS AND DISSEMINATION
Given the nature of the systematic review process, ethical 
and safety considerations are minimal. No concerns are 
held relating to the reuse of patient data for new research 
or the need to seek further informed consent. The review 
will collate, synthesise and present previously published 
aggregate patient data. No concerns are held relating to 
patient confidentiality. There are no plans for data depo-
sition or curation. If publications or data with ethical 
concerns are identified by the review, although unlikely, 
they will be excluded. Any amendments made to the 
protocol subsequent to its publication will initially be high-
lighted on PROSPERO and indicated with a date. They 
will then be provided as a dated addendum to this manu-
script. Findings will be published in a relevant academic 
journal and authors will engage with researchers through 
academic fora and key stakeholders.
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